Aviva PLC Global Blood Therapeutics, Inc. Transaction History

Aviva PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$38.94 - $50.85 $915,518 - $1.2 Million	-23,511 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$37.65 - $63.77 $717,609 - $1.22 Million	-19,060 Reduced 44.77%	23,511 $1.02 Million
Q3 2020 Nov 12, 2020	BUY	$52.76 - $74.49 $434,003 - $612,754	8,226 Added 23.95%	42,571 $2.35 Million
Q2 2020 Aug 13, 2020	SELL	$48.73 - $81.82 $1.79 Million - $3 Million	-36,686 Reduced 51.65%	34,345 $2.17 Million
Q1 2020 May 14, 2020	BUY	$41.72 - $87.2 $1.54 Million - $3.23 Million	37,028 Added 108.9%	71,031 $3.63 Million
Q4 2019 Feb 10, 2020	BUY	$45.7 - $81.86 $1.55 Million - $2.78 Million	34,003 New	34,003 $2.7 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

Stay updated on Aviva PLC with notifications on news.